Zobrazeno 1 - 10
of 63
pro vyhledávání: '"James F. Morley"'
Autor:
Pavan A. Vaswani, James F. Morley, Danna Jennings, Andrew Siderowf, Kenneth Marek, the PARS Investigators
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract There is disagreement in the literature whether olfaction may show specific impairments in Parkinson Disease (PD) and if olfactory tests comprised of selected odors could be more specific for diagnosis. We sought to validate previously propo
Externí odkaz:
https://doaj.org/article/7c41107a71f2452e9155c0c557015a71
Autor:
Kimberly J. Waddell, PhD, MSCI, Mitesh S. Patel, MD, MBA, Jayne R. Wilkinson, MD, MSCE, Robert E. Burke, MD, MS, FHM, Dawn M. Bravata, MD, Sreelatha Koganti, BS, Stephanie Wood, BS, James F. Morley, MD, PhD
Publikováno v:
Archives of Rehabilitation Research and Clinical Translation, Vol 5, Iss 1, Pp 100250- (2023)
Objective: The objective of this pilot study was to examine the feasibility of a remote physical activity monitoring program, quantify baseline activity levels, and examine predictors of activity among rurally residing adults with Parkinson disease (
Externí odkaz:
https://doaj.org/article/57857d95f8d44bba9c6bc428fad15e31
Autor:
Whitley W. Aamodt, Jacob G. Dubroff, Gang Cheng, Betty Taylor, Stephanie Wood, John E. Duda, James F. Morley
Publikováno v:
npj Parkinson's Disease, Vol 8, Iss 1, Pp 1-6 (2022)
Abstract Drug-induced parkinsonism (DIP) can be clinically indistinguishable from degenerative parkinsonism, and bedside assessments are needed to differentiate between these conditions. We examined 34 U.S. Veterans with DIP using 123I-FP-CIT (DAT-SP
Externí odkaz:
https://doaj.org/article/b1eb3f21f6b04c8abc1be63b6c0c99fe
Publikováno v:
Clinical Autonomic Research. 32:463-476
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e2ba313880111a85bef956e1fcf1ff
https://doi.org/10.1007/s10286-022-00889-8
https://doi.org/10.1007/s10286-022-00889-8
Autor:
Pavan A. Vaswani, James F. Morley, Danna Jennings, Andrew Siderowf, Kenneth Marek, Ken Marek, John Seibyl, Matthew Stern, David Russell, Kapil Sethi, Samuel Frank, Tanya Simuni, Robert Hauser, Bernard Ravina, Irene Richards, Grace Liang, Charles Adler, Rachel Saunders-Pullman, Marian L. Evatt, Eugene Lai, Indu Subramanian, Penelope Hogarth, Kathryn Chung
Publikováno v:
Parkinsonismrelated disorders. 104
The Parkinson Associated Risk Syndrome (PARS) study was designed to evaluate whether screening with olfactory testing and dopamine transporter (DAT) imaging could identify participants at risk for developing Parkinson's disease (PD).Hyposmia on a sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3d20869465fa9f2b672615d541915ff
https://pubmed.ncbi.nlm.nih.gov/36194902
https://pubmed.ncbi.nlm.nih.gov/36194902
Autor:
Ian M. Walker, Katheryn A. Cousins, Andrew Siderowf, John E. Duda, James F. Morley, Nabila Dahodwala, Thomas Tropea, Sanjeev Vaishnavi, David A. Wolk, Alice S. Chen-Plotkin, Leslie M. Shaw, Edward B. Lee, John Q. Trojanowski, Murray Grossman, Daniel Weintraub, David J. Irwin
Publikováno v:
Parkinsonism Relat Disord
Motor features of Parkinson’s disease (PD) are heterogeneous and well-studied; non-tremor features of postural instability and gait dysfunction (PIGD) have been linked to worse outcomes and Alzheimer’s disease (AD) co-pathology. However, these fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d923063d2a5b87fcd560bc85c8e4c21
https://europepmc.org/articles/PMC10078247/
https://europepmc.org/articles/PMC10078247/
Autor:
Andrew Siderowf, Nabila Dahodwala, Murray Grossman, Andres Deik, James F. Morley, Leslie M. Shaw, Meredith Spindler, David J. Irwin, Erica Howard, Thomas F. Tropea, John Q. Trojanowski, Naomi Nevler, John E. Duda, David A. Wolk, Katheryn A.Q. Cousins, Sanjeev N. Vaishnavi, Dawn Mechanic-Hamilton, Alice Chen-Plotkin, Sanjana Shellikeri, Daniel Weintraub, Katya Rascovsky
Publikováno v:
Neurology
ObjectiveTo determine whether patients with Lewy body dementia (LBD) with likely Alzheimer disease (AD)–type copathology are more impaired on confrontation naming than those without likely AD-type copathology.MethodsWe selected 57 patients with LBD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0cf019120251431e8d29d0c1d25d8ea
https://doi.org/10.1212/wnl.0000000000011699
https://doi.org/10.1212/wnl.0000000000011699
Autor:
James F. Morley, Nabila Dahodwala, Leslie M. Shaw, John E. Duda, John Q. Trojanowski, Murray Grossman, Sanjeev N. Vaishnavi, David G. Coughlin, Corey T. McMillan, Alice Chen-Plotkin, David A. Wolk, Meredith Spindler, David J. Irwin, Christopher Olm, Nicola Spotorno, Daniel Weintraub, Andres Deik, Edward B. Lee
Publikováno v:
Annals of clinical and translational neurology, vol 7, iss 12
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology
ObjectivesTo investigate the impact of Alzheimer's disease (AD) co-pathology on an in vivo structural measure of neurodegeneration in Lewy body disorders (LBD).MethodsWe studied 72 LBD patients (Parkinson disease (PD)=2, PD-MCI=25, PD with dementia=1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343075fffa49bdf13ce115d2fe00be86
https://doi.org/10.1002/acn3.51183
https://doi.org/10.1002/acn3.51183
Autor:
Daniel Weintraub, Benjamin L. Deck, Jacqueline Rick, John E. Duda, Sharon X. Xie, Andrew Siderowf, Rachael Purri, Alice Chen-Plotkin, John Q. Trojanowski, Rizwan S. Akhtar, Nabila Dahodwala, Lana M. Chahine, Laura Brennan, James F. Morley
Publikováno v:
Mov Disord
Objective The objective of this study was to determine the frequency and impact of subjective cognitive complaint (SCC) in Parkinson's disease (PD) patients with normal cognition. Methods Patients with PD with expert consensus-determined normal cogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5b937b6fc766a0ffe4a91b4a195452a
https://doi.org/10.1002/mds.28115
https://doi.org/10.1002/mds.28115
Publikováno v:
Tremor and Other Hyperkinetic Movements. 12
The last decade has seen development of numerous novel antipsychotic drugs with unique mechanisms including long-acting formulations for clinical use. A comparative assessment of these new drugs with each other and previous antipsychotics have not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e711c0b85d260812782e1b2ffeae66
https://doi.org/10.5334/tohm.695
https://doi.org/10.5334/tohm.695